Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05543512 · ClinicalTrials.gov registry record · NA
The Immune Directed Individualized Elimination Therapy (iDIET) Study
A NA study of Eosinophilic Esophagitis and EoE, sponsored by University of North Carolina, Chapel Hill.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT05543512: Active NA study of Eosinophilic Esophagitis and EoE, sponsored by University of North Carolina, Chapel Hill.
NCT05543512 is a NA study of Eosinophilic Esophagitis and EoE that is active but no longer recruiting, run by University of North Carolina, Chapel Hill. The registered enrollment target is 100 participants, below the 862-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05543512, a NA study of Eosinophilic Esophagitis and EoE, is active but no longer recruiting, sponsored by University of North Carolina, Chapel Hill.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized, double blind, sham-controlled, pilot/feasibility trial of individualized dietary elimination treatment.
Primary Outcome
Post-treatment peak eosinophil count (measured in eos/hpf)
Conditions Studied
Interventions
- DEVICE Algorithm to diagnose food allergens
- OTHER Sham diet
Study Locations (1)
North Carolina
- The University of North Carolina at Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-10-14 |
| Est. Completion | 2026-03 |
| Phase | NA |
What the registry record for NCT05543512 still lists
NCT05543512 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 862-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (88% lower).
The record links to 2 conditions, with Eosinophilic Esophagitis appearing as the primary indexed condition, and to 2 interventions - of which Algorithm to diagnose food allergens is the first listed.
NCT05543512 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05543512 about?
NCT05543512 is a clinical study titled "The Immune Directed Individualized Elimination Therapy (iDIET) Study". This is a randomized, double blind, sham-controlled, pilot/feasibility trial of individualized dietary elimination treatment.
What is the current status of trial NCT05543512?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-10-14. Estimated completion is 2026-03.
What conditions does trial NCT05543512 study?
This clinical trial studies the following conditions: Eosinophilic Esophagitis, EoE.
What interventions are being tested in trial NCT05543512?
The interventions under investigation include: Algorithm to diagnose food allergens (DEVICE), Sham diet (OTHER).
Who is sponsoring clinical trial NCT05543512?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05543512 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eosinophilic Esophagitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05543512's enrollment target sits among peer trials
100 18th of 44 higher than 26 of 44 other Eosinophilic Esophagitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Eosinophilic Esophagitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient-Centered Decision Support for Eosinophilic Esophagitis
RECRUITING · NA
-
The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States
RECRUITING · NA
-
Using Spectrally Encoded Confocal Microscopy (SECM) to Image the Esophagus
ACTIVE NOT RECRUITING · NA
-
Cytosponge and Dietary Therapy in EoE
COMPLETED · NA
-
Use of Esophageal String Test to Understand Symptoms, Inflammation, and Function in Eosinophilic Esophagitis
COMPLETED · NA
-
A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI